9 May 2025 in Trends in Parasitology
12 January 2025 in bioRxiv
Malaria disrupts neurocognitive homeostasis in humans, including in the non-severe manifestation of the disease - which is the most prevalent form of malaria in the world. This disruption is classically observed in human and experimental models of cerebral malaria. More recently, we demonstrated that this can also be observed in an experimental model of non-severe malaria and that Th2-immune response improves cognition and attenuates anxiety-like behavior associated to malaria. Complementarily, we have been studying the effect of physical exercise in restoring the neurocognitive homeostasis lost after non-severe murine malaria.
13 December 2019 in bioRxiv
Elements of the immune system are necessary for healthy neurocognitive function, and the pattern of the immune response triggered by different exogenous stimuli may induce regulatory or deregulatory signals that can affect nervous functions. Here we investigate the effect of immune stimulation on behavioural parameters in healthy mice and its impact on cognitive sequelae resulting from non-severe experimental malaria. We show that the immune modulation induced by a specific combination of immune stimuli, classically described as capable of inducing a major type 2 immune response, can improve the long-term memory of healthy adult mice and prevent the negative cognitive-behavioural impairments caused by a single episode of mildPlasmodium bergheiANKA malaria. This finding has implications for the development of immunogens as cognitive adjuvants.
1 January 2025 in Brazilian Journal of Medical and Biological Research
Malaria is a parasitic disease of great relevance in global public health. The development of new sensitive and specific diagnostic high-throughput methods remains a challenge in the eradication of this disease. In this study, we developed a flow cytometry test using latex microbeads and polyclonal antibodies obtained from rabbits and mice for the detection of the P. vivax lactate dehydrogenase (PvLDH) antigen. We processed 50 samples from Brazilian patients diagnosed with malaria caused by P. vivax and 40 samples from healthy individuals. The assay presented sensitivity of 64%, specificity of 97%, a positive predictive value of 97%, and a negative predictive value of 57% when analyzed using the fluorescent labeling method. Using the mean fluorescence intensity (MFI) analysis method, the sensitivity was 53%, specificity was 89%, the positive predictive value was 95%, and the negative predictive value was 33%. In both methods of analysis, we observed significant statistical differences between the analyzed groups (P-value <0.0001). A high correlation (0.60) between the two methods and a low correlation between PvLDH concentration and parasite density was found. The test was able to detect the PvLDH protein with high specificity, but its sensitivity should be improved. More promising results were observed when the samples were analyzed according to the percentage of fluorescent labeling. Improvement of this assay would enable its application as a serological test for the detection of asymptomatic patients and for the validation of rapid diagnostic tests.